Covid-19 Resources
Coronavirus Aid, Relief, and Economic Security (CARES) Act
By Doug Tardio President, CEOand Patrick MurphyExecutive Vice-President, Chief Financial Officer As part of the recently enacted Coronavirus Aid, Relief, and Economic Security (CARES) Act, $350 billion has been set aside to provide small businesses quick access to capital for payroll and other overhead costs. The program is referred to as the Paycheck Protection Program and funds … Read more Coronavirus Aid, Relief, and Economic Security (CARES) Act
Leveraging Pre-Visit Laboratory Testing to Optimize Visits: Augmenting Telerheumatology Accuracy and In-Person Visit Safety
By Andrew L. Concoff, MD, FACR, CAQSM The transition to Telerheumatology involves changes to the physical examination from that typically performed at an in-person visit. In Telerheumatology, greater emphasis is placed on inspection to account for the lack of palpation, auscultation, percussion. However, these changes may make the transition to Telerheumatology an anxiety-provoking and uncertain … Read more Leveraging Pre-Visit Laboratory Testing to Optimize Visits: Augmenting Telerheumatology Accuracy and In-Person Visit Safety
Special Coding Advice About Telehealth During The COVID-19 Emergency
On Friday, March 27, Sheppard Mullin, the legal partner for United Rheumatology, conducted a webinar on telehealth and all of the emerging changes in response to the Covid-19 pandemic that physician practices need to know and understand in order to provide the care their patients need and deserve in these difficult times. Over 80 of … Read more Special Coding Advice About Telehealth During The COVID-19 Emergency
Ardent Hopes Versus Proven Benefits: The Perils of Indiscriminate Antimalarial Prescription for COVID-19
By Andrew L. Concoff, MD, FACR, CAQSM The potential of the antimalarials, hydroxychloroquine and chloroquine, to treat COVID-19 infection has generated significant enthusiasm. The initial, nascent data that supports this notion comes in a variety of forms: clinical knowledge of the efficacy of these medications in treating other intracellular pathogens, in vitro data indicating a … Read more Ardent Hopes Versus Proven Benefits: The Perils of Indiscriminate Antimalarial Prescription for COVID-19
Additional Resources For Rheumatologists
- The CDC provides information to lead practice leaders through a risk assessment.
It can be accessed at https://www.cdc.gov/coronavirus/2019-ncov/hcp/assess-manage-risk.html. - An algorithmic approach to decision making in such circumstances can be found at https://www.cdc.gov/coronavirus/2019-ncov/downloads/public-health-management-decision-making.pdf.
- An example of how one member practice is communicating with their patients and staff: Practice Document.pdf
- Guiding Principles from the American College of Rheumatology for Scarce Resource Allocation During the COVID-19 Pandemic: The Case of Hydroxychloroquine
Dr. Alvin Wells, a UR Medical Policy Committee Member answers questions on converting to Telemedicine for the Rheumatologist